SG10202102695UA - Novel tilapia virus and uses thereof - Google Patents

Novel tilapia virus and uses thereof

Info

Publication number
SG10202102695UA
SG10202102695UA SG10202102695UA SG10202102695UA SG10202102695UA SG 10202102695U A SG10202102695U A SG 10202102695UA SG 10202102695U A SG10202102695U A SG 10202102695UA SG 10202102695U A SG10202102695U A SG 10202102695UA SG 10202102695U A SG10202102695U A SG 10202102695UA
Authority
SG
Singapore
Prior art keywords
novel
tilapia virus
virus
novel tilapia
tilapia
Prior art date
Application number
SG10202102695UA
Inventor
W Ian Lipkin
Thomas Briese
Nischay Mishra
Eran Bacharach
Avi Eldar
Original Assignee
Univ Columbia
Univ Ramot
Kimron Veterinary Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Univ Ramot, Kimron Veterinary Inst filed Critical Univ Columbia
Publication of SG10202102695UA publication Critical patent/SG10202102695UA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/00034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/00021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/00034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
SG10202102695UA 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof SG10202102695UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462091824P 2014-12-15 2014-12-15

Publications (1)

Publication Number Publication Date
SG10202102695UA true SG10202102695UA (en) 2021-04-29

Family

ID=56127461

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201704887SA SG11201704887SA (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof
SG10202102695UA SG10202102695UA (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof
SG10201901053TA SG10201901053TA (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201704887SA SG11201704887SA (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201901053TA SG10201901053TA (en) 2014-12-15 2015-12-15 Novel tilapia virus and uses thereof

Country Status (12)

Country Link
US (4) US10183072B2 (en)
CN (2) CN107427570A (en)
BR (1) BR112017012852A2 (en)
CO (1) CO2017007105A2 (en)
CR (1) CR20210528A (en)
EC (1) ECSP17045428A (en)
HK (1) HK1244700A1 (en)
IL (3) IL252919B (en)
MX (2) MX2021002525A (en)
MY (2) MY192642A (en)
SG (3) SG11201704887SA (en)
WO (1) WO2016100328A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia lake virus vaccines
EP3400007A4 (en) * 2016-01-10 2019-08-28 Abic Biological Laboratories Ltd. Orthomyxo-like virus of tilapia
CN108018377B (en) * 2017-12-07 2021-07-20 中国水产科学研究院珠江水产研究所 RT-LAMP (reverse transcription loop-mediated isothermal amplification) detection primer group, kit and method for Luo lake virus
CN108018378A (en) * 2017-12-11 2018-05-11 中国水产科学研究院珠江水产研究所 A kind of Luohu virus Taq-man fluorescence probe quantitative PCRs detection kit and detection method
CN108192869A (en) * 2018-01-24 2018-06-22 武汉轻工大学 A kind of channel catfish head-kidney macrophage primary isolated culture method and application
CN108220483A (en) * 2018-02-12 2018-06-29 深圳出入境检验检疫局动植物检验检疫技术中心 A kind of reagent, detection method and application for Tilapia mossambica lake viral diagnosis
CN109234451B (en) * 2018-09-26 2021-04-16 中国水产科学研究院长江水产研究所 Tilapia parvovirus TiPV CPA detection primer and application thereof
CN109852588B (en) * 2018-12-24 2023-03-07 中国水产科学研究院珠江水产研究所 Monoclonal antibody of anti-tilapia immune globulin IgM, cell strain and application thereof
CN110616281A (en) * 2019-10-29 2019-12-27 周伟光 Method for quantitatively detecting Luo lake virus by using real-time fluorescent RT-PCR
CN111436390B (en) * 2020-04-20 2021-11-16 中国热带农业科学院热带生物技术研究所 Temperature regulation culture system and method for reducing mortality of TiLV to tilapia
CN113122510A (en) * 2021-04-12 2021-07-16 中国水产科学研究院黑龙江水产研究所 Infectious hematopoietic necrosis vaccine and method for amplifying virus thereof on phoxinus fatigani muscle cells
CN113718061B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Primer set, kit and method for simultaneously detecting double RT-PCR of rochu virus and viral nervous necrosis virus
CN113755645B (en) * 2021-09-30 2023-06-09 厦门海关技术中心 Fluorescent quantitative RT-PCR primer pair and probe for detecting rochu virus, kit and detection method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737730B1 (en) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc PROCESS FOR PURIFYING VIRUSES BY CHROMATOGRAPHY
MXPA04001660A (en) 2001-08-27 2004-11-22 Advanced Bionutrition Corp Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses.
AU2002233969A1 (en) * 2001-12-07 2003-06-23 Schweitzer Chemical Corporation Usa Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
US8796436B2 (en) * 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
WO2008108660A2 (en) 2007-03-07 2008-09-12 Nofima Akvaforsk-Fiskeriforskning As Fish disease detection
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US9623099B2 (en) * 2012-09-26 2017-04-18 Fvg Limited Subunit immersion vaccines for fish
IL230970A0 (en) 2014-02-13 2014-09-30 Univ Ramot Tilapia lake virus vaccines

Also Published As

Publication number Publication date
CN114057841A (en) 2022-02-18
SG10201901053TA (en) 2019-03-28
US20170360918A1 (en) 2017-12-21
CR20210528A (en) 2021-12-06
SG11201704887SA (en) 2017-07-28
US10596249B2 (en) 2020-03-24
BR112017012852A2 (en) 2018-01-09
MY176597A (en) 2020-08-18
US10973902B2 (en) 2021-04-13
US10183072B2 (en) 2019-01-22
IL252919A0 (en) 2017-08-31
MX2021002525A (en) 2022-06-02
MY192642A (en) 2022-08-29
IL286265A (en) 2021-10-31
WO2016100328A8 (en) 2017-01-19
US20180369360A1 (en) 2018-12-27
US20200254084A1 (en) 2020-08-13
WO2016100328A1 (en) 2016-06-23
MX371220B (en) 2020-01-08
CN107427570A (en) 2017-12-01
MX2017007876A (en) 2018-11-09
ECSP17045428A (en) 2018-07-31
CO2017007105A2 (en) 2018-01-05
HK1244700A1 (en) 2018-08-17
IL252919B (en) 2022-07-01
US11583579B2 (en) 2023-02-21
IL266234A (en) 2019-06-30
US20210205437A1 (en) 2021-07-08

Similar Documents

Publication Publication Date Title
IL286265A (en) Novel tilapia virus and uses thereof
HK1254848A1 (en) Ancestral virus sequences and uses thereof
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL249184A0 (en) Anti-tnf-alpha glycoantibodies and uses thereof
IL247344A0 (en) Novel polysaccharide and uses thereof
HK1231471A1 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2-
ZA201700165B (en) Influenza virus vaccines and uses thereof
IL246755A0 (en) Heteroaryls and uses thereof
GB201403875D0 (en) Novel antibodies and uses thereof
GB201413913D0 (en) Novel antibodies and uses thereof
HUE044571T2 (en) Modified cyclopentapeptides and uses thereof
GB201406608D0 (en) Virus
SG11201610443WA (en) Influenza virus vaccines and uses thereof
IL247185B (en) Tilapia lake virus vaccines
GB201405784D0 (en) Novel methods, polypeptides and uses thereof
IL287985A (en) Koc1-derived peptide and vaccine including same
GB201419572D0 (en) Virus
IL251289B (en) Novel peptide derivatives and uses thereof
SG11201610918RA (en) Peptides and uses thereof
IL249705B (en) Influenza virus vaccines and uses thereof
IL249704A0 (en) Influenza virus vaccines and uses thereof
GB201600380D0 (en) Modified virus
GB201406470D0 (en) Virus
GB201403582D0 (en) Virus